Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Illumina Inc (ILMN)

Illumina Inc (ILMN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 47,733,840
  • Shares Outstanding, K 147,000
  • Annual Sales, $ 3,333 M
  • Annual Income, $ 826,000 K
  • 60-Month Beta 1.05
  • Price/Sales 14.06
  • Price/Cash Flow 44.79
  • Price/Book 10.79

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 14 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate 1.59
  • Number of Estimates 8
  • High Estimate 1.64
  • Low Estimate 1.55
  • Prior Year 1.32
  • Growth Rate Est. (year over year) +20.45%

Price Performance

See More
Period Period Low Period High Performance
1-Month
312.83 +3.80%
on 01/13/20
339.63 -4.39%
on 01/10/20
+1.27 (+0.39%)
since 12/17/19
3-Month
279.76 +16.07%
on 10/25/19
339.63 -4.39%
on 01/10/20
+14.17 (+4.56%)
since 10/17/19
52-Week
263.30 +23.33%
on 09/10/19
380.76 -14.72%
on 07/10/19
+14.67 (+4.73%)
since 01/17/19

Most Recent Stories

More News
Best Relative Performance in the Life Sciences Tools & Services Industry Detected in Shares of Neogenomics Inc (NEO , PRAH , ILMN , WAT , TMO )

We looked at the Life Sciences Tools & Services industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength....

ILMN : 324.72 (-0.38%)
NEO : 32.05 (-1.69%)
PRAH : 106.17 (-0.10%)
Illumina to Announce Fourth Quarter and Fiscal Year 2019 Financial Results on Wednesday, January 29, 2020

Illumina, Inc. (NASDAQ:ILMN) today announced that it will issue results for fourth quarter and fiscal year 2019 following the close of market on Wednesday, January 29, 2020.

ILMN : 324.72 (-0.38%)
Illumina Announces New Sequencing System, Partnership with Roche and Software Suite to Accelerate Adoption of Genomics

Illumina, Inc. (NASDAQ: ILMN) further demonstrated its commitment to making genomics more accessible for the potential benefit of patients today with a series of technology and partnership announcements...

ILMN : 324.72 (-0.38%)
Illumina and Roche Partner to Broaden Patient Access to Genomic Testing

Illumina, Inc. (NASDAQ: ILMN), the global leader in DNA sequencing and array-based technologies, and Roche, a global pioneer in pharmaceuticals and diagnostics, today announced a 15-year, non-exclusive...

ILMN : 324.72 (-0.38%)
Illumina Files Patent Infringement Suits Against BGI in Sweden and the United Kingdom

Illumina, Inc. (NASDAQ: ILMN) today announced that it has filed two additional patent infringement suits relating to BGI's sequencing products, including the DNBSeq-400 (also known as MGISeq-2000), DNBSeq-T7,...

ILMN : 324.72 (-0.38%)
ArcherDX and Illumina Partner for Future to Co-Market Portfolio of Planned In-Vitro Diagnostic (IVD) Tests

ArcherDX, Inc. today announced a non-exclusive, multi-year partnership with Illumina, Inc. (NASDAQ: ILMN) intended to broaden access of next generation sequencing (NGS)-based oncology testing, including...

ILMN : 324.72 (-0.38%)
SmarTrend Watching for Potential Pullback in Shares of Illumina Inc After 1.03% Gain

Illumina Inc (NASDAQ:ILMN) traded in a range yesterday that spanned from a low of $332.91 to a high of $334.99. Yesterday, the shares gained 1.0%, which took the trading range above the 3-day high of...

ILMN : 324.72 (-0.38%)
EBS vs. ILMN: Which Stock Is the Better Value Option?

EBS vs. ILMN: Which Stock Is the Better Value Option?

EBS : 55.56 (-0.86%)
ILMN : 324.72 (-0.38%)
Why Illumina (ILMN) is Poised to Beat Earnings Estimates Again

Illumina (ILMN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

ILMN : 324.72 (-0.38%)
Illumina Stock Slips on Pacific Biosciences Deal Termination

Per Illumina (ILMN), the lengthy route to achieve regulatory nods for the transaction induces uncertainty about the ultimate outcome of the integration.

OMCL : 85.93 (-1.82%)
HAE : 113.85 (-1.86%)
ILMN : 324.72 (-0.38%)
WST : 157.59 (-0.49%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Average short term outlook on maintaining the current direction.

See More Share

Trade ILMN with:

Business Summary

Illumina, Inc. is improving human health by unlocking the power of the genome. Their focus on innovation has established them as the global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical and applied markets. Their products are used for applications...

See More

Key Turning Points

2nd Resistance Point 331.84
1st Resistance Point 328.28
Last Price 324.72
1st Support Level 320.81
2nd Support Level 316.90

See More

52-Week High 380.76
Fibonacci 61.8% 335.89
Last Price 324.72
Fibonacci 50% 322.03
Fibonacci 38.2% 308.17
52-Week Low 263.30

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar